New study aims to uncover hidden barriers to early liver cancer detection

NCT ID NCT07312162

Recruiting now Knowledge-focused Sponsor: University of Southern California Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at why some people are diagnosed with liver cancer at a late stage, when treatment is harder. Researchers will survey 730 patients in Los Angeles about social and economic challenges like transportation, food, and housing. They will also interview doctors and community leaders to understand the full picture. The goal is to find ways to help more people get diagnosed early.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify the main barriers to early liver cancer detection, leading to better screening programs for at-risk communities.
What could go wrong: This is an observational study, not a treatment trial. It will not directly cure or treat liver cancer, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA

Contacts and locations

Locations

USC / Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.